ABL Diagnostics (FR001400AHX6 – ABLD, the“Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce an exclusive distribution agreement with Genient Tech Private Ltd. ( ).

Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay ...

The global bacterial diagnostics in aquaculture market expanded at a CAGR of 4.6% between 2018 and 2022. Based on aquatic animals, carp estimated a market share of 21.4% in 2022. Based on technique, ...

This important study shows that the Nora virus, a natural Drosophila pathogen that also persistently infects many laboratory fly stocks, infects intestinal stem cells (ISCs), leading to a shorter life ...

India’s intensified TB elimination strategy is deploying AI-powered handheld X-ray machines. These devices, combined with ...

A Chinese research team has successfully developed a triplex real-time quantitative fluorescence PCR method capable of ...

Roughly one out of three women ages 14-49 in the United States develop a vaginal bacterial imbalance known as bacterial ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the first patient has been ...

It is five years since Covid-19 crossed borders and it is time to revisit the lessons learnt from its catastrophic nature. The pandemic did put a strain on the global healthcare system, but at the ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Applied DNA Clinical Labs has submitted a validation package to the New York State Department of Health to request ...